CN1739711A - Externally applied medicine of rhodiola root - Google Patents
Externally applied medicine of rhodiola root Download PDFInfo
- Publication number
- CN1739711A CN1739711A CN 200510098940 CN200510098940A CN1739711A CN 1739711 A CN1739711 A CN 1739711A CN 200510098940 CN200510098940 CN 200510098940 CN 200510098940 A CN200510098940 A CN 200510098940A CN 1739711 A CN1739711 A CN 1739711A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- medicine
- rhizoma
- external use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention is one kind of externally applied medicine. The medicine is prepared with seven kinds of Chinese medicinal materials including rhodiola root, spine aralia, lucid phymatodes rhizome, scorpion, nutagrass flatsedge rhizome, etc. in certain proportion as well as alcohol solution in 75 % concentration. The synergistic effect of the Chinese medicinal materials makes the externally applied medicine possess high and determined effect and short treatment period on rheumarthritis, arthralgia, traumatic injury and other diseases.
Description
Technical field:
The present invention relates to a kind of Radix Rhodiolae medicine for external use.
Background technology:
The traumatic injury disease is a kind of common disease, it is a lot of from ancient times to the present to suffer from the somebody, be subjected to ailing the torment deeply, the various medicine for external use of Xiao Shouing are also a lot of in the market, but no matter be Western medicine or Chinese medicine, slight illness for this class Drug therapy traumatic injury has played certain therapeutical effect really, but does not also have a kind of specific drug of ideal treatment traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at pressing for of patient, eutherapeutic medicine for external use; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compare with existing similar medicine for external use curative effect, better efficacy is a kind of medicine for external use of very ideal traumatic injury.
Purpose of the present invention just provides a kind of Radix Rhodiolae medicine for external use.
Choice of drug Radix Rhodiolae of the present invention, Radix araliae armatae, Phymatodes lucida (Ro Xb.) Ching, Scorpio, Rhizoma Cyperi, Rhizoma Et Radix Notopterygii, Herba Desmodii Elegantis,, ethanol (concentration is 75%) forms; Wherein select Radix Rhodiolae for use: have promoting blood circulation and hemostasis; Can control traumatic injury.Select Radix araliae armatae for use: have dissipating blood stasis for subsidence of swelling, expelling wind and removing dampness; Can control traumatic injury, rheumatic ostalgia.Select Phymatodes lucida (Ro Xb.) Ching for use: have promoting blood circulation and stopping pain, the synthetism detumescence; Can control traumatic injury, lumbago and skelalgia.Select Scorpio for use: have wind-expelling pain-stopping, the collateral dredging detoxifcation; But dispelling the wind and dampness pathogens numbness poison, bones and muscles pain.Select Rhizoma Cyperi for use: have diffusing blood blood stasis removing; Can control traumatic injury.Select Rhizoma Et Radix Notopterygii for use: have diffusing exterior cold, wind-damp dispelling, sharp joint; Can control joint and ache anemofrigid-damp arthralgia.Select Herba Desmodii Elegantis for use: have dissipating blood stasis for subsidence of swelling.But dispelling the wind and dampness pathogens osteodynia.Make the effect of each medicine produce collaborative effect these drug regimens, thereby can realize effectively treating rheumatic arthritis, joint is ached, the curative effect of disease of wind and cold osteodynia, bones and muscles pain, rheumatalgia, lumbago and skelalgia, traumatic injury, treating swelling and pain by traumatic injury is definite, the course of treatment is shorter, and effect is better.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
Radix Rhodiolae 1-13 part, Radix araliae armatae 1-13 part, Phymatodes lucida (Ro Xb.) Ching 1-10 part, Scorpio 1-6 part, Rhizoma Cyperi 1-8 part, Rhizoma Et Radix Notopterygii 1-10 part, Herba Desmodii Elegantis 1-12 part, ethanol (concentration is 75%) 30-240 part.
Optimization formula of the present invention is:
11 parts of Radix Rhodiolaes, 11 parts of Radix araliae armatae, 8 parts of Phymatodes lucida (Ro Xb.) Chings, 4 parts of Scorpios, 6 parts of Rhizoma Cyperis, 8 parts of Rhizoma Et Radix Notopterygiis, 10 parts of Herba Desmodii Elegantiss, 190 parts of ethanol (concentration is 75%).
A kind of Radix Rhodiolae medicine for external use of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be applicable to that treatment rheumatic arthritis, joint ache the disease of wind and cold osteodynia, bones and muscles pain, rheumatalgia, lumbago and skelalgia, traumatic injury, treating swelling and pain by traumatic injury; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compares a kind of Radix Rhodiolae medicine for external use of better efficacy with existing similar medicine for external use curative effect.Radix Rhodiolae medicine for external use of the present invention was once done a large amount of clinical trials in early stage, during 2000-2005, give surplus the example 600 of curing the disease example time, comprise be used for the treatment of rheumatic arthritis, joint is ached, the disease of wind and cold osteodynia, bones and muscles pain, rheumatalgia, lumbago and skelalgia, traumatic injury, treating swelling and pain by traumatic injury is not seen untoward reaction during the treatment.Total effective rate is more than 88%, and the treatment works well.
Using method:
This medicine is a medicine for external use, and oral administration is cleaned the affected part with hot water, dabs in the affected part with the drenched medicinal liquid of absorbent cotton, rubs or beat affected part with the hands with the palm of the hand then, is good to making the affected part heating, every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Radix Rhodiolae medicine for external use provided by the present invention is made up of the component of following parts by weight; Radix Rhodiolae 1-13 part, Radix araliae armatae 1-13 part, Phymatodes lucida (Ro Xb.) Ching 1-10 part, Scorpio 1-6 part, Rhizoma Cyperi 1-8 part, Rhizoma Et Radix Notopterygii 1-10 part, Herba Desmodii Elegantis 1-12 part, ethanol (concentration is 75%) 30-240 part.
Embodiment 2:
Optimization formula of the present invention is:
11 parts of Radix Rhodiolaes, 11 parts of Radix araliae armatae, 8 parts of Phymatodes lucida (Ro Xb.) Chings, 4 parts of Scorpios, 6 parts of Rhizoma Cyperis, 8 parts of Rhizoma Et Radix Notopterygiis, 10 parts of Herba Desmodii Elegantiss, 190 parts of ethanol (concentration is 75%).
Preparation method of the present invention is: at first with above-mentioned Radix Rhodiolae, Radix araliae armatae, Phymatodes lucida (Ro Xb.) Ching, Scorpio, Rhizoma Cyperi, Rhizoma Et Radix Notopterygii, Herba Desmodii Elegantis, the single granularity control of grinding into is as the grain of rice between the size respectively, granule after each single pulverizing is mixed in proportion mixes together evenly, be placed in the container then, and allocate ethanol (concentration is 75%) into, stir in the sealed container of back, according to the modern Chinese medicine processing technology or after soaking 15 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.
Claims (3)
1, a kind of Radix Rhodiolae medicine for external use is characterized in that: Radix Rhodiolae, Radix araliae armatae, Phymatodes lucida (Ro Xb.) Ching, Scorpio, Rhizoma Cyperi, Rhizoma Et Radix Notopterygii, Herba Desmodii Elegantis, ethanol (concentration is 75%) are formed.
2, a kind of Radix Rhodiolae medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; Radix Rhodiolae 1-13 part, Radix araliae armatae 1-13 part, Phymatodes lucida (Ro Xb.) Ching 1-10 part, Scorpio 1-6 part, Rhizoma Cyperi 1-8 part, Rhizoma Et Radix Notopterygii 1-10 part, Herba Desmodii Elegantis 1-12 part, ethanol (concentration is 75%) 30-240 part.
3, a kind of Radix Rhodiolae medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; 11 parts of Radix Rhodiolaes, 11 parts of Radix araliae armatae, 8 parts of Phymatodes lucida (Ro Xb.) Chings, 4 parts of Scorpios, 6 parts of Rhizoma Cyperis, 8 parts of Rhizoma Et Radix Notopterygiis, 10 parts of Herba Desmodii Elegantiss, 190 parts of ethanol (concentration is 75%).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510098940 CN1739711A (en) | 2005-09-11 | 2005-09-11 | Externally applied medicine of rhodiola root |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510098940 CN1739711A (en) | 2005-09-11 | 2005-09-11 | Externally applied medicine of rhodiola root |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1739711A true CN1739711A (en) | 2006-03-01 |
Family
ID=36092336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510098940 Pending CN1739711A (en) | 2005-09-11 | 2005-09-11 | Externally applied medicine of rhodiola root |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1739711A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103989886A (en) * | 2014-06-12 | 2014-08-20 | 潘宝珍 | Pharmaceutical composition capable of removing lead as well as preparation method and application thereof |
| CN107375615A (en) * | 2017-07-14 | 2017-11-24 | 巴桑此里 | A kind of medicinal liquor for treating treating swelling and pain by traumatic injury and its preparation method and application |
-
2005
- 2005-09-11 CN CN 200510098940 patent/CN1739711A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103989886A (en) * | 2014-06-12 | 2014-08-20 | 潘宝珍 | Pharmaceutical composition capable of removing lead as well as preparation method and application thereof |
| CN107375615A (en) * | 2017-07-14 | 2017-11-24 | 巴桑此里 | A kind of medicinal liquor for treating treating swelling and pain by traumatic injury and its preparation method and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742895A (en) | External-use medicine of Herba sarcandrae | |
| CN1739711A (en) | Externally applied medicine of rhodiola root | |
| CN1813944A (en) | External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals | |
| CN1813992A (en) | Radix-zauthoxyli-Plamispini external-use collateral-flow-activating medicine for treating injuries from falls | |
| CN1739693A (en) | Externally applied medicine of dunn tongoloa root | |
| CN1739740A (en) | Externally applied medicine of fewleaf schnabelia herb | |
| CN1739646A (en) | Externally applied medicine of thickleaf croton root | |
| CN1813898A (en) | External-use medicine of hayberry bark for traumatic injury and activating collaterals | |
| CN1742801A (en) | Qianjinba external-use medicine | |
| CN1813928A (en) | External-use drug of canavalia gladiata for traumatic injury and activating collaterals | |
| CN1751709A (en) | External use medicine for treating traumatic injury | |
| CN1739708A (en) | Externally applied medicine of cannalike dona rhizome | |
| CN1739624A (en) | Externally applied medicine of aizoon stonecrop root | |
| CN1813854A (en) | External-use medicine of herb of seguin cobelia for traumatic injury and activating collaterals | |
| CN1813963A (en) | External medicine of Herbaet Rhizoma Begoniae cavalerei for treating traumatic injuries and activating collateral flows | |
| CN1739634A (en) | Externally applied medicine of safflower | |
| CN1739702A (en) | Externally applied medicine of citronella | |
| CN1739649A (en) | Externally applied wound treating medicine of miquel brookweed | |
| CN1739670A (en) | Externally applied medicine of avicenna's pricklyash root | |
| CN1739690A (en) | Externally applied medicine of Himalayan blueberry herb | |
| CN1813942A (en) | External-use drug of helwingia himalaicahook for traumatic injury and activating collaterals | |
| CN1813990A (en) | Cortex Berheridis Radicis external-use medicine | |
| CN1813907A (en) | External-use medicine of cordateleaf ainsliaea root for traumatic injury and activating collaterals | |
| CN1813864A (en) | External-use medicine of thickleaf croton root for traumatic injury and activating collaterals | |
| CN1751726A (en) | Fine spike acanthaceous external use medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |